Pharmacytimes: Condition Center: Acute Coronary Syndrome http://www.pharmacytimes.com/condition-resources/acs/condition-rss Acute Coronary Syndrome en-us Fri, 20 Oct 2017 04:59:34 UTC Fri, 20 Oct 2017 04:59:34 UTC The Role of Rivaroxaban in Stable Cardiovascular Disease http://www.pharmacytimes.com/contributor/marilyn-bulloch-pharmd-bcps/2017/10/the-role-of-rivaroxaban-in-stable-cardiovascular-disease Rivaroxaban with or without aspirin was evaluated for the secondary prevention of cardiovascular outcomes 1:22 AM, Tue October 10, 2017 5 Lipid-Lowering Studies Pharmacists Should Know About http://www.pharmacytimes.com/contributor/timothy-o-shea/2017/08/5-lipid-lowering-studies-pharmacists-should-know-about A number of landmark clinical studies on lipid lowering and cardiovascular health have been published, shaping how patients are treated. 11:47 PM, Thu August 24, 2017 All That Is Old Becomes New Again: New Roles for Old, Antiplatelets in STEMI http://www.pharmacytimes.com/contributor/douglas-jennings-pharmd-fccp-faha/2017/08/all-that-is-old-becomes-new-again-new-roles-for-old-antiplatelets-in-stemi This article discusses the potential role of tirofiban as a complementary agent to the newer oral P2Y12 receptor blockers in STEMI patients. 1:22 AM, Thu August 10, 2017 Adherence to Statins after ACS: What's Your Baseline? http://www.pharmacytimes.com/resource-centers/acs/adherence-to-statins-after-acs-whats-your-baseline Patients who experience acute coronary syndrome need high-intensity statin therapy.&nbsp; 7:00 AM, Fri April 21, 2017 Using Morphine in Acute Myocardial Infarction: A Potential Mistake? http://www.pharmacytimes.com/contributor/alexander-kantorovich-pharmd-bcps/2017/04/using-morphine-in-acute-myocardial-infarction-a-potential-fatal-mistake Morphine and Ticagrelor Drug Interaction 10:27 PM, Mon April 3, 2017 Health Groups Call for FDA to Ban All Flavored Tobacco Products http://www.pharmacytimes.com/news/health-groups-call-for-fda-to-ban-all-flavored-tobacco-products &nbsp;<br /> Several public health and antismoking groups are urging the FDA to enforce more stringent regulations on the manufacturing of tobacco products&nbsp;by banning candy and fruit-flavored e-cigarettes and cigars.&nbsp; 10:55 AM, Tue March 21, 2017 Herbal Medications and Patients with Heart Disease: What to Discuss http://www.pharmacytimes.com/resource-centers/acs/herbal-medications-and-patients-with-heart-disease-what-to-discuss- Herbal medications remain popular among this patient population group.&nbsp; 10:19 AM, Tue February 28, 2017 4 Essential Pharmacotherapy Findings from ESC Congress 2016 http://www.pharmacytimes.com/contributor/douglas-jennings-pharmd-fccp-faha/2016/08/4-essential-pharmacotherapy-findings-from-esc-congress-2016 Many exciting clinical trial results are being presented at ESC Congress 2016 and published simultaneously this week. 11:18 PM, Tue August 30, 2016 Is Ticagrelor Superior to Clopidogrel in Real-World ACS Patients? http://www.pharmacytimes.com/contributor/douglas-jennings-pharmd-fccp-faha/2016/08/is-ticagrelor-superior-to-clopidogrel-in-real-world-acs-patients Clinical trial data don't always reflect real-world experience. 11:37 PM, Sun August 14, 2016 Statin Use in HIV Patients Taking Protease Inhibitors http://www.pharmacytimes.com/resource-centers/hiv/statin-use-in-hiv-patients-taking-protease-inhibitors HIV infection is a proinflammatory condition predisposing patients to arteriosclerosis, diabetes mellitus, dyslipidemia, and vascular thrombosis. 10:55 PM, Sun July 31, 2016 How Health-System Pharmacists Can Improve Adherence in Patients with Acute Coronary Syndrome http://www.pharmacytimes.com/publications/health-system-edition/2016/July2016/how-health-system-pharmacists-can-improve-adherence-in-patients-with-acute-coronary-syndrome At the ASHP 2016 Summer Meetings, Christopher Betz, PharmD, BCPS, FKSHP, FASHP, shared some of the ways pharmacists can use motivational interviewing to improve adherence in ACS patients. 10:36 PM, Tue July 26, 2016 What the Smoker's Paradox Means for ACS Patients http://www.pharmacytimes.com/resource-centers/ACS/what-the-smokers-paradox-means-for-acs-patients A lifetime of smoking shortens life expectancy by a decade or more. 9:09 PM, Tue July 26, 2016 FDA Requests Additional Information for Aggrastat http://www.pharmacytimes.com/product-news/fda-rejects-expanded-indication-for-aggrastat The FDA reviews Medicure Inc&acirc;&euro;&trade;s supplemental new drug application for Aggrastat. 7:00 AM, Thu July 21, 2016 Wearable Cardioverter Defibrillators: A Safety Net for ACS Patients http://www.pharmacytimes.com/resource-centers/ACS/wearable-cardioverter-defibrillators-a-safety-net-for-acs-patients Sudden cardiac arrest occurs 424,000 times outside of the hospital annually. 10:43 PM, Sun July 17, 2016 State Trends in Secondhand Smoke Laws http://www.pharmacytimes.com/resource-centers/ACS/state-trends-in-secondhand-smoke-laws Do you smoke?" is often the first question health care providers ask when patients experience symptoms suggestive of acute coronary syndrome. 8:59 AM, Tue June 28, 2016 Morphine for Myocardial Infarction: Pros and Cons http://www.pharmacytimes.com/resource-centers/ACS/morphine-for-myocardial-infarction-pros-and-cons Myocardial infarction is a painful condition with tightness, pressure, or squeezing pain in the chest for approximately 75% of patients who experience it. 8:49 AM, Wed June 22, 2016 Cardio-Cousins: Heart Failure, Atrial Fibrillation, and Acute Coronary Syndrome http://www.pharmacytimes.com/publications/issue/2016/June2016/Cardio-Cousins-Heart-Failure-Atrial-Fibrillation-and-Acute-Coronary-Syndrome Cardiovascular disease accounts for 30% of all deaths worldwide, and it is not just 1 disease. 1:49 AM, Thu June 9, 2016 A Quick Summary of P2Y12 Inhibitor Interactions http://www.pharmacytimes.com/resource-centers/ACS/a-quick-summary-of-p2y12-inhibitor-interactions More than 1 million Americans have an acute coronary syndrome event annually, and more than 400,000 individuals die from ACS events each year. 9:38 PM, Tue June 7, 2016 PCSK9 Inhibitors: What Pharmacists Should Know http://www.pharmacytimes.com/contributor/timothy-o-shea/2016/06/pcsk9-inhibitors-what-pharmacists-should-know This article highlights several key therapeutics areas for PCSK9 inhibitors that every pharmacist should know. 10:01 PM, Tue May 31, 2016 Female ACS Patients Face Greater Risks for Adverse Events After PCI http://www.pharmacytimes.com/resource-centers/ACS/female-acs-patients-face-greater-risks-for-adverse-events-after-pci Women with acute coronary syndrome are more likely than men to experience a major adverse cardiac event and bleeding 1 year after undergoing percutaneous coronary intervention. 1:22 AM, Fri May 27, 2016